2018.03 Received the 13th Five-Year Major Science and Technology Special Support
2017.12 The company's stock was successfully issued, and the financing was 50 million yuan.
2017.11 Strategic cooperation with JVC Corporation of the United States, introduction of JVS-100, launch of research and development in the field of
2017.10 The accumulated contract amount exceeded 100 million ¥118,770,800
2017.03 Successfully landed on the new three board OC: 870803
2016.11 Won the "National High-tech Enterprise"
2016.07 Mr. Li, Chairman of the Board of Directors, was selected as the “National High-level Talent Special Support Plan” (Million Plan)
2016.06 Won the "Jiangsu Private Technology Enterprise"
2016.05 Introducing strategic investors, financing 21 million yuan
2016.01 Received the first batch of support from the National Head Fund, the National SME Development Fund
2015.12 Introduced angel investors, financing 13 million yuan
2015.09 The company moved to Nanjing Life Science Town
2015.03 Ms. Huo Liru, the general manager, was awarded the “Nanjing Technology Entrepreneur”
2013.12 Ms. Huo Liru, the general manager, was awarded “321 Talents in Nanjing”
2013.11.08 The birth of Gritpharma